Skip to main content Accessibility help
×
Home
Hostname: page-component-564cf476b6-scc96 Total loading time: 0.504 Render date: 2021-06-20T20:06:02.493Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true }

Dysphagia in the neuroleptic malignant syndrome

Published online by Cambridge University Press:  02 January 2018

J. Shamash
Affiliation:
Department of Metabolic Medicine and Metabolism, St. Mary's Hospital, Praed Street, London W2 1NY
L. Miall
Affiliation:
Department of Metabolic Medicine and Metabolism, St. Mary's Hospital, Praed Street, London W2 1NY
F. Williams
Affiliation:
Department of Metabolic Medicine and Metabolism, St. Mary's Hospital, Praed Street, London W2 1NY
D. Creamer
Affiliation:
Department of Metabolic Medicine and Metabolism, St. Mary's Hospital, Praed Street, London W2 1NY
S. Robinson
Affiliation:
Department of Metabolic Medicine and Metabolism, St. Mary's Hospital, Praed Street, London W2 1NY
D. G. Johnston
Affiliation:
Department of Metabolic Medicine and Metabolism, St. Mary's Hospital, Praed Street, London W2 1NY
Rights & Permissions[Opens in a new window]

Abstract

Image of the first page of this article. For PDF version, please use the ‘Save PDF’ preceeding this image.
Type
Columns
Copyright
Copyright © 1994 The Royal College of Psychiatrists 

References

Bristow, M. F. & Kohen, D. (1993) How ‘malignant$’ is the neuroleptic malignant syndrome? British Medical Journal. 307, 12231224.CrossRefGoogle ScholarPubMed
Gratz, S. S., Levinson, D. F. & Simpson, G. M. (1992) The treatment and management of the neuroleptic malignant syndrome. Neuropsychopharmacology-Biology-Psychiatry, 16, 425443.CrossRefGoogle Scholar
Katzung, B. G. (ed.) (1989) Basic and Clinical Pharmacology, pp. 264275, 338–339. Englewood Cliffs, NJ: Prentice Hall International(USA).Google Scholar
Walker, G. (1994) ABPI Data Sheet Compendium 1993–4, pp. 703706. London: Datapharm Publications.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.
You have Access
1
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Dysphagia in the neuroleptic malignant syndrome
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Dysphagia in the neuroleptic malignant syndrome
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Dysphagia in the neuroleptic malignant syndrome
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *